Lentigen Gains Exclusive, World-Wide License
to Multisubstrate Kinase Gene Technology
Baltimore, Maryland and Lyngby, Denmark January 9, 2006
Lentigen Corporation
and ZGene A/S announced today they have entered into Read More...
Baltimore, MD, December 13, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of lentiviral
vectors, announced that the company has secured financing through the state of
Read More...
Alliance Provides Potential Customers with Access to Lentiviral Vector Expertise and
cGMP Manufacturing Capabilities
Baltimore and Rockville, MD, December 6, 2005
Lentigen Corporation, a privately
Read More...
Industry and Academic Veterans Launch Operations for Lentiviral Technology
Baltimore, Maryland, December 2, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of res Read More...
Funding to Launch Breakthrough Delivery Technology for Biologics
Baltimore, MD, November 30, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of lentiviral
vectors, announced that Read More...
Baltimore, MD, November 14, 2005
Lentigen Corporation, a privately owned biotechnology company focused on manufacturing and developing research and therapeutic grade lentiviral vectors, announced today the launch of the first website devoted to provid Read More...
BALTIMORE , MD (July 22, 2005)
Lentigen Corporation has joined the
techcenter@UMBC Incubator Program. Lentigen is a start-up company that
focuses on harnessing the power of Lentiviral vector ( LV ) gene delivery and
expression technology for a wide v Read More...
